2020
DOI: 10.1186/s12888-020-02850-3
|View full text |Cite
|
Sign up to set email alerts
|

Validation of the PHQ-9 depression scale in Ethiopian cancer patients attending the oncology clinic at Tikur Anbessa specialized hospital

Abstract: Background Although depression is highly prevalent among cancer patients, it is often underdiagnosed and poorly managed particularly in developing nations. These shortcomings can have substantial adverse effects not only on the disease prognosis but also on patients’ quality of life. The Patient Health Questionnaire-9 is a widely used depression screening tool but it has not been validated among patients with chronic illnesses such as cancer in Ethiopia. We aim to validate the PHQ-9 among Ethiopian cancer pati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(33 citation statements)
references
References 28 publications
0
28
0
Order By: Relevance
“…The 9-item Patient Health Questionnaire (PHQ-9) was used to assess depression symptoms. The questionnaire was validated and developed by the local language, Afaan Oromo and Amharic language in the Ethiopian context and it recommended for use (31,32).…”
Section: Data Collection and Questionnairementioning
confidence: 99%
“…The 9-item Patient Health Questionnaire (PHQ-9) was used to assess depression symptoms. The questionnaire was validated and developed by the local language, Afaan Oromo and Amharic language in the Ethiopian context and it recommended for use (31,32).…”
Section: Data Collection and Questionnairementioning
confidence: 99%
“…The 9-item Patient Health Questionnaire (PHQ-9) tool was used to assess depression symptoms. The questionnaire was validated in the Ethiopian context and it recommended for use [26].…”
Section: Data Collection and Questionnairementioning
confidence: 99%
“…Primary exposure: depressive symptoms Depressive symptoms were measured using the Patient Health Questionnaire, 9-item version (PHQ-9) Kroenke et al, 2011]. Validity of the PHQ-9 tool in Ethiopia was investigated against the gold standard of the Mini International Neuropsychiatric Interview (MINI) diagnostic tool among cancer patients in Tikur Anbessa hospital, the national referral and teaching hospital, and showed a sensitivity of 88% and speci city of 78.1% to detect major depressive episode (MDE) [43]. Validity of the PHQ-9 for depression screening and the diagnosis was also done against psychiatrist administered semi-structure schedules for clinical assessment in neuropsychiatry (SCAN) interview among 926 Ethiopian adults in 2013 demonstrate good reliability and validity of the tool (sensitivity = 86% and speci city = 67%), Bizu Gelaye et al [44].…”
Section: Primary Outcome: Viral Load Suppressionmentioning
confidence: 99%